We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

95 hedge funds and large institutions have $213M invested in Amphastar Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,825% more call options, than puts

Call options by funds: $197K | Put options by funds: $4K

81% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 26

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

33% more capital invested

Capital invested by funds: $160M → $213M (+$52.3M)

3% more funds holding

Funds holding: 92 → 95 (+3)

Holders
95
Holders Change
+3
Holders Change %
+3.26%
% of All Funds
2.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
47
Reduced
26
Closed
8
Calls
$197K
Puts
$4K
Net Calls
+$193K
Net Calls Change
+$202K

Top Buyers

Rank Fund Capital Flow
1
TA
Teachers Advisors
New York
+$4.17M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.78M
3
State Street
State Street
Massachusetts
+$2.09M
4
BIT
BlackRock Institutional Trust
California
+$1.62M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.49M

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$3.57M
2
BC
Broadfin Capital
New York
-$3.3M
3
TC
TFS Capital
Pennsylvania
-$1.62M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.53M
5
BFA
BlackRock Fund Advisors
California
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
101
Rotella Capital Management
Washington
– -$152K -13,012 Closed
AIM
102
Ada Investment Management
New York
– -$116K -10,109 Closed
PSI
103
Pinnacle Summer Investments
Virginia
– -$34K -3,000 Closed
1 2 3 4
5

AMPH Hedge Fund Activity: Q4 2015 in Review

95 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2015, worth a combined $213M — up 33% from $160M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AMPH positions and 8 closed out — a net gain of 3 holders — while 47 added to existing stakes and 26 trimmed.

The largest buyer was Teachers Advisors, adding an estimated $4.17M. The largest seller was UBS AM, cutting an estimated $3.57M.

  • 95 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2015, up from 92 in Q3 2015.
  • Funds reported $213M of Amphastar Pharmaceuticals stock for Q4 2015, up 33% quarter-over-quarter.
  • 11 funds opened new Amphastar Pharmaceuticals positions in Q4 2015 and 8 closed out, a net change of +3 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q4 2015 was Teachers Advisors, an estimated $4.17M added.
  • The largest Amphastar Pharmaceuticals seller in Q4 2015 was UBS AM, an estimated $3.57M sold.

Based on aggregated 13F filings for Q4 2015.